Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
Overcoming Obstacles in AAV Viral Vector Manufacturing
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
View All Featured ArticlesHeadline News
Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study
Spruce separates CRHX-101 programme into new endocrinology company Adrenyx Biosciences
Livdelzi improves ALP normalisation rates in Phase III PBC study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Do Extractable Protocols Truly Help – An End User Perspective
Presented by Ekta Mahajan
05th February 2018
Mixed mode Chromatography in Purifying biologics – Overview
Presented by Vivek Halan, Senior Scientific manager at Zumutor Biologics Pvt Ltd
15th November 2018
Points to consider when defining a microbial control strategy for individualized ATMPs
Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















